Miraa (khat) occupies a unique and often contradictory position within Kenya’s legal framework, with one set of laws recognising it as an important cash crop while another regulatory regime treats it as a psychoactive substance requiring control.
The inconsistency has left unresolved questions over how the crop should be regulated and whether existing laws adequately reflect Kenya’s economic, public health and constitutional priorities.
The Constitution of Kenya, 2010, recognises agriculture as a devolved function under the Fourth Schedule, while Article 11 acknowledges culture as the foundation of the nation.
Miraa has long been cultivated and consumed in parts of Kenya, making it both an economic commodity and a crop with deep cultural roots.
Its commercial status is reinforced by the Crops Act, No. 16 of 2013, which lists miraa among Kenya’s scheduled crops. The law places the crop under the regulation of the Agriculture and Food Authority (AFA), providing for its production, marketing and development as part of the country’s agricultural sector. In practice, this means the Government promotes miraa farming, facilitates access to export markets and recognises it as a source of income for thousands of households.
The position becomes more complex when viewed through the lens of drug control legislation. Although the Narcotic Drugs and Psychotropic Substances (Control) Act, No. 4 of 1994 does not expressly list miraa as a narcotic drug, the National Authority for the Campaign Against Alcohol and Drug Abuse (NACADA), established under the NACADA Act, No. 14 of 2012, classifies khat as a psychoactive substance because it contains cathinone and cathine, naturally occurring stimulants capable of affecting the central nervous system.
The result is that the same plant is promoted as an agricultural commodity while simultaneously being the subject of public health campaigns discouraging its consumption. This dual approach creates uncertainty in policy implementation and public understanding.
The contradiction is further reflected internationally. Kenya exports miraa as a legal agricultural product, yet several countries, including the United States, Canada and parts of Europe, prohibit or tightly regulate khat because of its stimulant properties.
These differing international standards have periodically disrupted Kenya’s export markets and affected farmers who depend on the crop for their livelihoods.
The legal distinction between cultivation and consumption also remains blurred. While farming and trading miraa are lawful under agricultural legislation, public health policies continue to caution against its use because of concerns over addiction, mental health, cardiovascular effects and reduced productivity among heavy users. This has created two parallel policy positions that are yet to be fully reconciled.
The question is therefore not simply whether miraa is a crop or a drug. It is whether Kenya’s legal framework should continue regulating it through separate agricultural and public health laws without a unified policy, or whether Parliament should harmonise the existing legislation to provide certainty for farmers, traders, regulators, law enforcement agencies and consumers.
Until that question is resolved, miraa will continue to occupy a grey area in Kenyan law—recognised as a legitimate cash crop under one statute while remaining the focus of drug control and public health interventions under another.
